One hundred thousand newborn babies in England will have their genomes sequenced, in a £105mn research programme that could pave the way for a full-scale neonatal screening plan to detect rare genetic conditions.
Genomics England, a government-owned company, aims to read all the DNA carried by a representative national sample of babies shortly after they are born. The two-year project, to be carried out in partnership with the NHS, will begin late next year.
“Generating this evidence will allow policymakers to make well informed decisions on whether and how whole genome sequencing could be rolled out as part of a future newborn screening programme,” said Richard Scott, chief medical officer of Genomics England.